Bone marrow transplantation after the Chernobyl nuclear accident
- PMID: 2664512
- DOI: 10.1056/NEJM198907273210401
Bone marrow transplantation after the Chernobyl nuclear accident
Erratum in
- N Engl J Med 1990 Jan 25;322(4):280
Abstract
On April 26, 1986, an accident at the Chernobyl nuclear power station in the Soviet Union exposed about 200 people to large doses of total-body radiation. Thirteen persons exposed to estimated total-body doses of 5.6 to 13.4 Gy received bone marrow transplants. Two transplant recipients, who received estimated doses of radiation of 5.6 and 8.7 Gy, are alive more than three years after the accident. The others died of various causes, including burns (the cause of death in five), interstitial pneumonitis (three), graft-versus-host disease (two), and acute renal failure and adult respiratory distress syndrome (one). There was hematopoietic (granulocytic) recovery in nine transplant recipients who could be evaluated, six of whom had transient partial engraftment before the recovery of their own marrow. Graft-versus-host disease was diagnosed clinically in four persons and suspected in two others. Although the recovery of endogenous hematopoiesis may occur after exposure to radiation doses of 5.6 to 13.4 Gy, we do not know whether it is more likely after the transient engraftment of transplanted stem cells. Because large doses of radiation affect multiple systems, bone marrow recovery does not necessarily ensure survival. Furthermore, the risk of graft-versus-host disease must be considered when the benefits of this treatment are being weighed.
Comment in
-
Chernobyl: learning from experience.N Engl J Med. 1989 Jul 27;321(4):254-5. doi: 10.1056/NEJM198907273210409. N Engl J Med. 1989. PMID: 2747761 No abstract available.
Similar articles
-
[A short review of the transplantation of hemopoietic tissues in the treatment of the victims of the accident at the Chernobyl Atomic Electric Power Station].Ter Arkh. 1991;63(12):83-5. Ter Arkh. 1991. PMID: 1687092 Review. Russian. No abstract available.
-
A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.Biol Blood Marrow Transplant. 2003 Jan;9(1):52-9. doi: 10.1053/bbmt.2003.50000. Biol Blood Marrow Transplant. 2003. PMID: 12533742
-
[Experience in treating the victims of the accident at the Chernobyl Atomic Electric Power Station and the immediate disease outcomes].Med Radiol (Mosk). 1991;36(3):29-32. Med Radiol (Mosk). 1991. PMID: 2017002 Russian.
-
Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.N Engl J Med. 2000 Jun 22;342(25):1846-54. doi: 10.1056/NEJM200006223422501. N Engl J Med. 2000. PMID: 10861319
-
Potential use of hematopoietic stem cells after radiation injury.Stem Cells. 1997;15 Suppl 2:305-10. doi: 10.1002/stem.5530150740. Stem Cells. 1997. PMID: 9368317 Review.
Cited by
-
Therapy-related myeloid neoplasms of recipient origin after allogeneic hematopoietic stem cell transplantation for acute leukemia.Int J Hematol. 2022 Dec;116(6):902-910. doi: 10.1007/s12185-022-03442-5. Epub 2022 Aug 28. Int J Hematol. 2022. PMID: 36030518
-
Overview: effects of radiation on the human body: acute and chronic sequelae in hematopoietic organs.Int J Hematol. 2012 Mar;95(3):225-6. doi: 10.1007/s12185-012-1030-0. Epub 2012 Feb 29. Int J Hematol. 2012. PMID: 22370712 No abstract available.
-
Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry.Antioxidants (Basel). 2022 May 31;11(6):1098. doi: 10.3390/antiox11061098. Antioxidants (Basel). 2022. PMID: 35739995 Free PMC article. Review.
-
Fast image analysis for the micronucleus assay in a fully automated high-throughput biodosimetry system.Radiat Res. 2014 Feb;181(2):146-61. doi: 10.1667/RR13441.1. Epub 2014 Feb 6. Radiat Res. 2014. PMID: 24502354 Free PMC article.
-
Gamma-radiated immunosuppressed tumor xenograft mice can be a new ideal model in cancer research.Sci Rep. 2021 Jan 8;11(1):256. doi: 10.1038/s41598-020-80428-5. Sci Rep. 2021. Retraction in: Sci Rep. 2023 Nov 15;13(1):19952. doi: 10.1038/s41598-023-46583-1. PMID: 33420261 Free PMC article. Retracted.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous